0001209191-17-039878.txt : 20170614 0001209191-17-039878.hdr.sgml : 20170614 20170614173145 ACCESSION NUMBER: 0001209191-17-039878 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170613 FILED AS OF DATE: 20170614 DATE AS OF CHANGE: 20170614 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sierra Oncology, Inc. CENTRAL INDEX KEY: 0001290149 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2150 ? 885 WEST GEORGIA STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 3E8 BUSINESS PHONE: 604-558-6536 MAIL ADDRESS: STREET 1: 2150 ? 885 WEST GEORGIA STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 3E8 FORMER COMPANY: FORMER CONFORMED NAME: ProNAi Therapeutics Inc DATE OF NAME CHANGE: 20040513 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pelzer Robert CENTRAL INDEX KEY: 0001297500 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37490 FILM NUMBER: 17911955 MAIL ADDRESS: STREET 1: C/O IDENIX PHARMACEUTICALS, INC. STREET 2: 60 HAMPSHIRE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-06-13 0 0001290149 Sierra Oncology, Inc. SRRA 0001297500 Pelzer Robert C/O SIERRA ONCOLOGY, INC. 2150 885 WEST GEORGIA ST. VANCOUVER A1 V6C 3E8 BRITISH COLUMBIA, CANADA 1 0 0 0 Stock Option (right to buy) 1.13 2017-06-13 4 A 0 25000 0.00 A 2027-06-13 Common Stock 25000 25000 D The option vests as to 8.333% of the total shares monthly, beginning on July 13, 2017, with 100% of the total shares vested and exercisable on June 13, 2018, subject to the reporting person's provision of service to the issuer on each vesting date. /s/ Sukhi Jagpal as attorney-in-fact for Robert Pelzer 2017-06-14